BR0014591A - Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida - Google Patents

Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida

Info

Publication number
BR0014591A
BR0014591A BR0014591-2A BR0014591A BR0014591A BR 0014591 A BR0014591 A BR 0014591A BR 0014591 A BR0014591 A BR 0014591A BR 0014591 A BR0014591 A BR 0014591A
Authority
BR
Brazil
Prior art keywords
polymorphic
dimethoxyphenyl
propyl
ethyl
amino
Prior art date
Application number
BR0014591-2A
Other languages
English (en)
Portuguese (pt)
Inventor
David Busby
Original Assignee
Glaxosmithkline Lab Sas
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Lab Sas, Smithkline Beecham Plc filed Critical Glaxosmithkline Lab Sas
Publication of BR0014591A publication Critical patent/BR0014591A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR0014591-2A 1999-10-08 2000-10-06 Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida BR0014591A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923933.7A GB9923933D0 (en) 1999-10-08 1999-10-08 Novel pharmaceutical
PCT/GB2000/003847 WO2001027071A1 (fr) 1999-10-08 2000-10-06 Hydrochlorure de benzamide n-[3-[[2-(3,4-dimethexyphenyl)ethyl]amino]propyl]-4-nitro polymorphe

Publications (1)

Publication Number Publication Date
BR0014591A true BR0014591A (pt) 2002-06-11

Family

ID=10862442

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014591-2A BR0014591A (pt) 1999-10-08 2000-10-06 Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida

Country Status (18)

Country Link
EP (1) EP1218334A1 (fr)
JP (1) JP2003511437A (fr)
KR (1) KR20020043618A (fr)
CN (1) CN1384817A (fr)
AU (1) AU7546000A (fr)
BR (1) BR0014591A (fr)
CA (1) CA2386845A1 (fr)
CZ (1) CZ20021189A3 (fr)
GB (1) GB9923933D0 (fr)
HK (1) HK1049147A1 (fr)
HU (1) HUP0203582A2 (fr)
IL (1) IL148966A0 (fr)
MX (1) MXPA02003516A (fr)
NO (1) NO20021639L (fr)
PL (1) PL354137A1 (fr)
TR (1) TR200200949T2 (fr)
WO (1) WO2001027071A1 (fr)
ZA (1) ZA200202679B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2664189T3 (es) 2002-01-09 2018-04-18 Emisphere Technologies, Inc. Polimorfos de 4-(4-cloro-2-hidroxibenzoil)aminobutanoato de sodio
KR101125932B1 (ko) * 2006-12-06 2012-03-22 아이디유엔 파마슈티칼즈, 인코포레이티드 (3ｓ)-3-［ｎ-(ｎ'-(2-ｔｅｒｔ-부틸페닐)옥사밀)알라니닐］아미노-5-(2',3',5',6'-테트라플루오로페녹시)-4-옥소펜탄산의 결정 형태

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726267B1 (fr) * 1994-10-26 1998-01-02 Smithkline Beecham Lab Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer
GB9706376D0 (en) * 1997-03-27 1997-05-14 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
TR200200949T2 (tr) 2002-08-21
JP2003511437A (ja) 2003-03-25
EP1218334A1 (fr) 2002-07-03
WO2001027071A1 (fr) 2001-04-19
CZ20021189A3 (cs) 2002-09-11
GB9923933D0 (en) 1999-12-08
IL148966A0 (en) 2002-11-10
MXPA02003516A (es) 2004-09-10
HUP0203582A2 (en) 2004-03-01
PL354137A1 (en) 2003-12-29
NO20021639L (no) 2002-05-30
ZA200202679B (en) 2003-05-28
HK1049147A1 (zh) 2003-05-02
CA2386845A1 (fr) 2001-04-19
NO20021639D0 (no) 2002-04-05
AU7546000A (en) 2001-04-23
CN1384817A (zh) 2002-12-11
KR20020043618A (ko) 2002-06-10

Similar Documents

Publication Publication Date Title
AR045317A1 (es) Forma cristalina de agonista dl receptor adrenergico b2
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR0008753B1 (pt) Composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida
BR0307529A (pt) Derivados de n-fenil-2-pirimidina-amina
PT1401445E (pt) Anticolinergico cristalino, processo para a sua preparacao e sua utilizacao para a preparacao de um medicamento
BR9910913A (pt) Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, e, processo para a profilaxia e/ou tratamento de condições clìnicas associadas com resistência a insulina
MY117971A (en) Denaturants for sympathomimetic amine salts
BR0113520A (pt) Processo de preparação de ácidos n-aril-antranìlicos e seus derivados
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
BR9911182B1 (pt) compostos derivados de biarila com propriedades agonistas de adrenorreceptores beta-3, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto.
PT973511E (pt) Utilizacao de analogos de sibutramina para baixar os niveis de lipidos
BR9404809A (pt) Composto, uso, formulação farmacêutica e processo para preparar um composto
HUP0302553A2 (hu) Egy izotiazol-4-karbonsavamid sói és eljárás az előállításukra és ezek alkalmazására a túlzott mértékű sejtburjánzás visszaszorítására alkalmas gyógyszerkészítmények előállítására
IS1954B (is) Alfa-hýdroxý, -amínó- og -flúoró afleiður beta-súlfonýlhýdroxamsýra notaðar sem tálmar við grindarmálmprótínkljúfum
BR0211691A (pt) Processo para a prepara de tolterodina
IT1319671B1 (it) Processo per la preparazione di (s)-n,n'-bis(2-idrossi-1-(idrossimetil)etil)-5-((2-idrossi-1-ossopropil)ammino)
BR0014591A (pt) Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida
IL155041A0 (en) Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds
BR0316400A (pt) agentes branqueadores fluorescentes anfotéricos
BR9810405A (pt) Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona
AR044175A1 (es) Compuestos de cefemo
BR9608820A (pt) Processo para a preparação de monoidrato de cloridreto de ropivacaína e monoidrato de cloridreto de ropivacaína
EE200200583A (et) (E)-N-(6,6-dimetüül-2-hepteen-4-ünüül)-N-metüül-1-naftaleenmetaanamiini (terbinafiin) valmistamise meetod
PL306538A1 (en) Substituted (aryloalkylaminobenzyl) amino propanamide derivatives, method of obtaining them and their application as antiepileptic, nervous system protecting and antidepressive agents
PT1235788E (pt) Processo para a preparacao de derivados de ariletanolamina com propriedades anti-obesidade e anti-diabeticas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]